BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38454495)

  • 1. Organelle resolved proteomics uncovers PLA2R1 as a novel cell surface marker required for chordoma growth.
    Khan S; Zuccato JA; Ignatchenko V; Singh O; Govindarajan M; Waas M; Mejia-Guerrero S; Gao A; Zadeh G; Kislinger T
    Acta Neuropathol Commun; 2024 Mar; 12(1):39. PubMed ID: 38454495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the phospholipase A2 receptor in liposome drug delivery in prostate cancer cells.
    Quach ND; Mock JN; Scholpa NE; Eggert MW; Payré C; Lambeau G; Arnold RD; Cummings BS
    Mol Pharm; 2014 Oct; 11(10):3443-51. PubMed ID: 25189995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CENPA knockdown restrains cell progression and tumor growth in breast cancer by reducing PLA2R1 promoter methylation and modulating PLA2R1/HHEX axis.
    Wu G; Fan Z; Li X
    Cell Mol Life Sci; 2024 Jan; 81(1):27. PubMed ID: 38212546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current insights into functions of phospholipase A2 receptor in normal and cancer cells: More questions than answers.
    Sukocheva O; Menschikowski M; Hagelgans A; Yarla NS; Siegert G; Reddanna P; Bishayee A
    Semin Cancer Biol; 2019 Jun; 56():116-127. PubMed ID: 29104026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation.
    Lateb M; Ouahmi H; Payré C; Brglez V; Zorzi K; Dolla G; Zaidan M; Boyer-Suavet S; Knebelmann B; Crépin T; Courivaud C; Jourde-Chiche N; Esnault V; Lambeau G; Seitz-Polski B
    J Immunol Res; 2019; 2019():1324804. PubMed ID: 32083137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma.
    Gulluoglu S; Sahin M; Tuysuz EC; Yaltirik CK; Kuskucu A; Ozkan F; Sahin F; Ture U; Bayrak OF
    Oncol Res; 2017 Aug; 25(7):1177-1188. PubMed ID: 28247842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of PLA2R1 by c-MYC and HIF-2alpha promotes cancer growth.
    Vindrieux D; Devailly G; Augert A; Le Calvé B; Ferrand M; Pigny P; Payen L; Lambeau G; Perrais M; Aubert S; Simonnet H; Dante R; Bernard D
    Oncotarget; 2014 Feb; 5(4):1004-13. PubMed ID: 24657971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Epithelial Phospholipase A
    Nolin JD; Ogden HL; Lai Y; Altemeier WA; Frevert CW; Bollinger JG; Naika GS; Kicic A; Stick SM; Lambeau G; Henderson WR; Gelb MH; Hallstrand TS
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):825-836. PubMed ID: 27448109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLA2R1 mediates tumor suppression by activating JAK2.
    Vindrieux D; Augert A; Girard CA; Gitenay D; Lallet-Daher H; Wiel C; Le Calvé B; Gras B; Ferrand M; Verbeke S; de Launoit Y; Leroy X; Puisieux A; Aubert S; Perrais M; Gelb M; Simonnet H; Lambeau G; Bernard D
    Cancer Res; 2013 Oct; 73(20):6334-45. PubMed ID: 24008317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase A2 receptor 1 promotes lung cell senescence and emphysema in obstructive lung disease.
    Beaulieu D; Attwe A; Breau M; Lipskaia L; Marcos E; Born E; Huang J; Abid S; Derumeaux G; Houssaini A; Maitre B; Lefevre M; Vienney N; Bertolino P; Jaber S; Noureddine H; Goehrig D; Vindrieux D; Bernard D; Adnot S
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 33509955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma.
    Liang C; Ma Y; Yong L; Yang C; Wang P; Liu X; Zhu B; Zhou H; Liu X; Liu Z
    Cancer Sci; 2019 Jan; 110(1):166-179. PubMed ID: 30426615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation of the M-type phospholipase A(2) receptor gene in leukemic cells.
    Menschikowski M; Platzbecker U; Hagelgans A; Vogel M; Thiede C; Schönefeldt C; Lehnert R; Eisenhofer G; Siegert G
    BMC Cancer; 2012 Dec; 12():576. PubMed ID: 23217014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes.
    Griveau A; Wiel C; Le Calvé B; Ziegler DV; Djebali S; Warnier M; Martin N; Marvel J; Vindrieux D; Bergo MO; Bernard D
    Aging Cell; 2018 Dec; 17(6):e12835. PubMed ID: 30216637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLA2R1: expression and function in cancer.
    Bernard D; Vindrieux D
    Biochim Biophys Acta; 2014 Aug; 1846(1):40-4. PubMed ID: 24667060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical and serological characterization of membranous nephropathy in children and adolescents.
    Dettmar AK; Wiech T; Kemper MJ; Soave A; Rink M; Oh J; Stahl RAK; Hoxha E;
    Pediatr Nephrol; 2018 Mar; 33(3):463-472. PubMed ID: 29034405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of survivin expression in 50 chordoma specimens--A histological and in vitro study.
    Froehlich EV; Rinner B; Deutsch AJ; Meditz K; Knausz H; Troppan K; Scheipl S; Wibmer C; Leithner A; Liegl B; Lohberger B
    J Orthop Res; 2015 May; 33(5):771-8. PubMed ID: 25640185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental study on differences in clivus chordoma bone invasion: an iTRAQ-based quantitative proteomic analysis.
    Wu Z; Wang L; Guo Z; Wang K; Zhang Y; Tian K; Zhang J; Sun W; Yu C
    PLoS One; 2015; 10(3):e0119523. PubMed ID: 25793716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylthioadenosine phosphorylase and activated insulin-like growth factor-1 receptor/insulin receptor: potential therapeutic targets in chordoma.
    Sommer J; Itani DM; Homlar KC; Keedy VL; Halpern JL; Holt GE; Schwartz HS; Coffin CM; Kelley MJ; Cates JM
    J Pathol; 2010 Apr; 220(5):608-17. PubMed ID: 20140939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
    Bosotti R; Magnaghi P; Di Bella S; Cozzi L; Cusi C; Bozzi F; Beltrami N; Carapezza G; Ballinari D; Amboldi N; Lupi R; Somaschini A; Raddrizzani L; Salom B; Galvani A; Stacchiotti S; Tamborini E; Isacchi A
    Sci Rep; 2017 Aug; 7(1):9226. PubMed ID: 28835717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells.
    Menschikowski M; Hagelgans A; Nacke B; Jandeck C; Sukocheva O; Siegert G
    BMC Cancer; 2015 Dec; 15():971. PubMed ID: 26672991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.